Statin pleiotropism and atherosclerotic plaque rupture
- 31 October 2009
- journal article
- other
- Published by Elsevier in Atherosclerosis
- Vol. 206 (2) , 353-354
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Statin prevents plaque disruption in apoE-knockout mouse model through pleiotropic effect on acute inflammationAtherosclerosis, 2009
- Protective Role of CXC Receptor 4/CXC Ligand 12 Unveils the Importance of Neutrophils in AtherosclerosisCirculation Research, 2008
- Effect of Fluvastatin and Valsartan, Alone and in Combination, on Postprandial Vascular Inflammation and Fibrinolytic Activity in Patients With Essential HypertensionJournal of Cardiovascular Pharmacology, 2007
- Assessment of Unstable Atherosclerosis in MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery diseaseJournal of Thrombosis and Haemostasis, 2006
- Plaque Rupture After Short Periods of Fat Feeding in the Apolipoprotein E–Knockout MouseCirculation, 2005
- The Effects of Atorvastatin Treatment on the Fibrinolytic System in Dyslipidemic PatientsJapanese Heart Journal, 2004
- HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statinsBritish Journal of Pharmacology, 2002
- Pravastatin: An Antithrombotic Effect Independent of the Cholesterol-lowering EffectThrombosis and Haemostasis, 2000
- Effect of Fluvastatin on Lipids and Fibrinolysis in Coronary Artery DiseaseThe American Journal of Cardiology, 1997